-
Chromothripsis followed by circular recombination drives oncogene amplification in human cancer
Study
EGAS00001005424
-
Combined targeting of BRD4-associated Promoter Activation and NFKB Immunomodulation in ARID1A-mutated Gastric Adenocarcinoma
Study
EGAS00001006397
-
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients
Study
EGAS00001004491
-
Genome analysis of early onset sporadic rectal cancer
Study
EGAS00001005970
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-5)
Study
EGAS00001006114
-
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer; a post-hoc analysis of the randomized controlled trial AGITG-MAX
Study
EGAS00001005453
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
Transcriptome sequencing of Gingivo-buccal Cancer : ICGC-India Project_Batch05
Study
EGAS00001003285
-
RNA sequencing of undifferentiated sarcomas
Study
EGAS00001003291
-
Whole genome sequencing of tumour and matched normal from patients with family history of breast cancer
Study
EGAS00001003305
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Non-small cell lung cancer proteome subtypes expose targetable oncogenic drivers and immune evasion mechanisms
Study
EGAS00001005482
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
RNA sequencing data of 142 samples from 142 patients with HER2+ breast cancer treated with letrozole or tamoxifen (SOLTI PAMELA trial)
Study
EGAS00001006410
-
Whole genome sequencing of colorectal cancer patients (SG-BULK-1)
Study
EGAS00001006030
-
Genomewide copy number alteration screening of circulating plasma DNA
Study
EGAS00001006031
-
MutWP5__CRUK_Mutographs_of_Cancer__Breast__Cancer_Mastectomy__WG_
Study
EGAS00001003317
-
Res1_H23_exp1_MC_04_03_22
Study
EGAS00001006091
-
Exome sequencing of paired primary tumor and metastatic breast cancer
Study
EGAS00001004578
-
Functional screening on patient-derived organoids identifies a therapeutic bispecific antibody that triggers EGFR degradation in LGR5+ tumor cells
Study
EGAS00001004584
-
MutWP5__CRUK_Mutographs_of_Cancer__Breast__Cancer_Mastectomy__Targeted_
Study
EGAS00001003318
-
MutWP5__CRUK_Mutographs_of_Cancer__Breast__Cancer_Mastectomy__Exome_
Study
EGAS00001003319
-
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Study
EGAS00001004614